A new way to store and cool vaccines during the last mile of their journey to the clinic claimed the £5000 in the 2016/17 competition.
The University of Cambridge’s Kitty Liao and Imperial College London’s Abellona U claimed the first prize which will go towards their start-up company ‘Ideabatic’. Their life-saving vaccine cooling and delivery system ‘SMILE’ aims to deliver vaccines to the 19 million unvaccinated children living in the most remote areas of the world.
According to the World Health Organisation, every year, two to three million children die of vaccine-preventable diseases and in 2016, there were 19.4 million children who are unable to receive basic vaccinations. One of the main contributing factors to these figures is that the cool boxes currently used for delivering vaccines to the most remote regions, termed ‘the last-mile journey’, are inadequate. A typical last-mile journey takes between two to seven days. However, the cool boxes currently used can only maintain vaccines to be within the required temperature range of two to eight degrees Celsius for up to 14 hours. As a result, 20 to 50 percent of the vaccines are spoiled during the last-mile journey, which amounts to an annual total of 600 million dollars’ worth of vaccines being wasted globally. Ideabatic is developing SMILE, a smart last-mile vaccine delivery system to address this issue.
“I founded Ideabatic with a vision to solve global challenges with innovations and to further develop SMILE- Smart Last-Mile Vaccine Cooling and Delivery System for the Developing World. We are raising funding and building a consortium to optimise and launch SMILE. Please join us to reach every child no matter how difficult the journey is.” said winner Kitty Liao, 1st year postgraduate student within theJudge Business School at the University of Cambridge.
Winner Abellona U, first year PhD student in Clinical Medicine Research at Imperial said “We are very grateful to IGHI for organising this competition and encourage students to work on innovative solutions to tackle global health challenges. We will work hard to bring SMILE to the real world!”
Runners up Jez Marston and Robert Learney from ‘Accunea’ won the £2500 prize money. Their aim is to develop real-time monitoring platform technology for early detection of acute kidney injury in patients after surgery.
“Competing in the Student Challenges Competition was a great way to test our idea and raise awareness around the need for innovation in kidney care worldwide. Both the application step and the final pitching event pushed us to refine our message and value proposition in improving global health” said Jez and Robert.
The Audience Choice Award went to Stephanie Hodgson, Istvan Ferrier, Vikram Palit and Max Renna for ‘CorVision’ an innovative and affordable screening tool that provides accurate and early detection of congenital cardiac disease (CCD) in newborns.
"Our journey through the IGHI competition has been a fantastic opportunity to develop CorVision further and really focus on the global health effect that this device could have. Throughout the competition process, we were able to better understand the problem of poor and late diagnosis of congenital cardiac disease, especially in developing regions. We are happy to have been awarded the Audience Choice Award, and this has given us the confidence (and capital) to take CorVision to the next level - and hopefully build a prototype. Our hope is that CorVision can help save the lives of vulnerable children around the world, through facilitating early screening and diagnosis".
Other finalists covered a range of topics including Salman Mailk from the University of Manchester, who aimed to revolutionise particle manufacture for pharmaceutical & research industries. Imperial’s Laura Mitchell, Chun Man Chow, Emily Groves, Raghd Rostom and Simon Wiegrebe offered a new way to provide low-cost access to diagnostic testing, whilst Azuolas Ciukas and Mantas Matjusaitis from the University of Edinburgh presented ‘CellAge’ which aims to improve human lifespan & reduce the incidence of age-related diseases. Imperial’s Mingxia Wang also offered a way to non-invasively monitor intracranial pressure.
The finalists pitched their ideas to four expert judges - Dr Richard Smith - IGHI Adjunct Professor, Chairman of Patients Know Best, Director of the UnitedHealth Chronic Disease Initiative, former Editor of the British Medical Journal and Chief Executive of the BMJ Publishing Group; Professor Simone Buitendijk – Imperial Vice-Provost for Education; Dr Will Cavendish – Strategy Lead, Applied at DeepMind; Dr Mark Hammond – Founder, Deep Science Ventures.